Monitoring Therapy Compliance of Tuberculosis Patients by using Video-Enabled Electronic Devices

Alistair Story, Richard S Garfein, Andrew Hayward, Valiantsin Rusovich, Andrei Dadu, Viorel Soltan, Alexandru Oprunenco, Kelly Collins, Rohit Sarin, Subhi Quraishi, Mukta Sharma, Giovanni Battista Migliori, Maithili Varadarajan, Dennis Falzon, Alistair Story, Richard S Garfein, Andrew Hayward, Valiantsin Rusovich, Andrei Dadu, Viorel Soltan, Alexandru Oprunenco, Kelly Collins, Rohit Sarin, Subhi Quraishi, Mukta Sharma, Giovanni Battista Migliori, Maithili Varadarajan, Dennis Falzon

Abstract

A recent innovation to help patients adhere to daily tuberculosis (TB) treatment over many months is video (or virtually) observed therapy (VOT). VOT is becoming increasingly feasible as mobile telephone applications and tablet computers become more widely available. Studies of the effectiveness of VOT in improving TB patient outcomes are being conducted.

Keywords: DOT; Tuberculosis; VOT; bacteria; computer communication networks; directly observed therapy; individualized medicine; medication adherence; short course; telemedicine; tuberculosis and other mycobacteria; video observed therapy; videoconferencing; virtually observed therapy.

References

    1. World Health Organization. Global tuberculosis report 2015. (WHO/HTM/TB/2015.22). Geneva: The Organization; 2015 [cited 2015 Oct 30].
    1. World Health Organization. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. WHO/HTM/TB/2014.11. Geneva: The Organization. 2014 [cited 2015 Oct 5].
    1. Borgdorff MW, Floyd K, Broekmans JF. Interventions to reduce tuberculosis mortality and transmission in low- and middle-income countries. Bull World Health Organ. 2002;80:217–27 .
    1. Toczek A, Cox H, du Cros P, Cooke G, Ford N. Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis. 2013;17:299–307. 10.5588/ijtld.12.0537
    1. Uplekar M, Weil D, Lönnroth K, Jaramillo E, Lienhardt C, Dias HM, et al. WHO’s new end TB strategy. Lancet. 2015;385:1799–801. 10.1016/S0140-6736(15)60570-0
    1. World Health Organization. TB—a global emergency. WHO/TB/94.177. Geneva: The Organization; 1994. [cited 2015 Oct 30].
    1. DeMaio J, Schwartz L, Cooley P, Tice A. The application of telemedicine technology to a directly observed therapy program for tuberculosis: a pilot project. Clin Infect Dis. 2001;33:2082–4. 10.1086/324506
    1. Krueger K, Ruby D, Cooley P, Montoya B, Exarchos A, Djojonegoro BM, et al. Videophone utilization as an alternative to directly observed therapy for tuberculosis. Int J Tuberc Lung Dis. 2010;14:779–81 .
    1. Mirsaeidi M, Farshidpour M, Banks-Tripp D, Hashmi S, Kujoth C, Schraufnagel D. Video directly observed therapy for treatment of tuberculosis is patient-oriented and cost-effective. Eur Respir J. 2015;46:871–4. 10.1183/09031936.00011015
    1. Garfein RS, Collins K, Muñoz F, Moser K, Cerecer-Callu P, Raab F, et al. Feasibility of tuberculosis treatment monitoring by video directly observed therapy: a binational pilot study. Int J Tuberc Lung Dis. 2015;19:1057–64. 10.5588/ijtld.14.0923
    1. Hayward A, Garber E. TB Reach 5: to compare the efficacy of video observed treatment (VOT) versus directly observed treatment (DOT) in supporting adherence in patients with active tuberculosis. 2014. Apr 17 [cited 2015 Oct 30].
    1. The Behavioural Insights Team. Virtually observed treatment (VOT) for tuberculosis patients in Moldova. [cited 2015 Oct 30].
    1. World Health Organization. Digital health for the End TB Strategy: an agenda for action. WHO/HTM/TB/2015.21. Geneva: The Organization; 2015 [cited 2015 Oct 30].
    1. Wasan KM, Thornton SJ, Bell I, Goulding RE, Gretes M, Gray AP, et al. The global access initiative at the University of British Columbia (UBC): Availability of UBC discoveries and technologies to the developing world. J Pharm Sci. 2009;98:791–4. 10.1002/jps.21495
    1. Guebert JM, Bubela T. Implementing socially responsible licensing for global health: beyond neglected diseases. Sci Transl Med. 2014. Oct 29;6(260):260cm11. PMID:25355695

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi